Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database

The primary goal of this investigation is to determine the current national standards for time to treatment initiation (TTI) in soft tissue sarcoma (STS). Additionally, we aim to identify the variables affecting TTI variability in STS.

• Publication year

  2018

• Venue

  Journal of Surgical Oncology

• Publication date

  2018-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.25095PMID 29949654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY

  2019cited by this paper
• Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers

  2017cited by this paper
• Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma

  2017cited by this paper
• Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

  2017cited by this paper
• Administrative Databases Can Yield False Conclusions-An Example of Obesity in Total Joint Arthroplasty.

  2017cited by this paper
• Using the National Cancer Database for Outcomes Research: A Review

  2017cited by this paper
• EARLY CANCER DIAGNOSIS SAVES LIVES, CUTS TREATMENT COSTS

  2017cited by this paper
• Treatment delay and facility case volume are associated with survival in early‐stage glottic cancer

  2017cited by this paper
• Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database

  2016cited by this paper
• Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

  2016cited by this paper
• Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

  2016cited by this paper
• Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

  2016cited by this paper
• Time to Surgery and Breast Cancer Survival in the United States.

  2016cited by this paper
• Routes to diagnosis for sarcoma - Describing the sarcoma patient journey.

  2015cited by this paper
• Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research.

  2015cited by this paper
• Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.

  2015cited by this paper
• Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database

  2015cited by this paper
• Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis

  2015cited by this paper
• Association of Short Duration From Initial Symptoms to Specialist Consultation With Poor Survival in Soft-Tissue Sarcomas

  2015cited by this paper
• One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.

  2015cited by this paper
• WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition

  2014cited by this paper
• Medical malpractice and sarcoma care—A thirty‐three year review of case resolutions, inciting factors, and at risk physician specialties surrounding a rare diagnosis

  2014cited by this paper
• Effect of marital status on treatment and survival of extremity soft tissue sarcoma.

  2014cited by this paper
• Outcomes in the management of adult soft tissue sarcomas

  2014cited by this paper
• Comparing national cancer registries: The National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program

  2014cited by this paper
• WHO classification of tumours of soft tissue and bone

  2013cited by this paper
• Primary excision compared with re‐excision of extremity soft tissue sarcomas—is anything new?

  2012cited by this paper
• Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?

  2012cited by this paper
• Wait Times in Diagnostic Evaluation and Treatment for Patients With Stage III Non-Small Cell Lung Cancer in British Columbia

  2012cited by this paper
• Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?

  2012cited by this paper
• Preoperative delays in the US Medicare population with breast cancer.

  2012cited by this paper
• The symptom‐to‐diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis

  2011cited by this paper
• Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006

  2011cited by this paper
• Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis.

  2011cited by this paper
• Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

  2010cited by this paper
• Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review.

  2010cited by this paper
• Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers

  2009cited by this paper
• A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

  2008cited by this paper
• Delays in Referral of Soft Tissue Sarcomas

  2008cited by this paper
• The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

  2008cited by this paper
• Cancer mortality in the United States by education level and race.

  2007cited by this paper
• Should Soft Tissue Sarcomas Be Treated at High-volume Centers?: An Analysis of 4205 Patients

  2007cited by this paper
• Does Length of Symptoms Before Diagnosis of Sarcoma Affect Patient Survival?

  2007cited by this paper
• Size matters for sarcomas!

  2006cited by this paper
• Delay in referral to a specialist soft-tissue sarcoma unit.

  2005cited by this paper
• Symptom interval in young people with bone cancer.

  2004cited by this paper
• Cancer Disparities by Race/Ethnicity and Socioeconomic Status

  2004cited by this paper
• Multiple primary soft tissue sarcomas

  2004cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• Analysis of the referral pattern to a supraregional bone and soft tissue tumour service.

  2003cited by this paper
• Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome.

  2003cited by this paper
• Delay in diagnosis of soft tissue sarcomas.

  2003cited by this paper
• Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

  2002cited by this paper
• Effect of reresection in extremity soft tissue sarcoma.

  2000cited by this paper
• Full Paper

  1999cited by this paper
• Exact Estimates for a Rate Ratio

  1996cited by this paper
• Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients.

  1994cited by this paper
• Who Classification of Soft Tissue Tumours

  year unknowncited by this paper

• Diagnostic Delay in Soft Tissue Sarcomas: A Review

  2025influential citation
• Delayed Treatment Associated With Worse Survival in High-grade Undifferentiated Pleomorphic Sarcoma.

  2025cites this paper
• Time to treatment initiation in primary extremity sarcomas: Determinants and oncological outcomes in a tertiary LMIC cancer center.

  2025cites this paper
• Simulation‐free workflow for lattice radiation therapy using deep learning predicted synthetic computed tomography: A feasibility study

  2025cites this paper
• Disparities in Survival and NCCN Guideline-Concordant Care in Patients With Extremity Soft Tissue Sarcoma.

  2024cites this paper
• Assessing Sarcoma Awareness Among the General Population in Minnesota: A Cross-Sectional Survey Study from the Minnesota State Fair in 2015 and 2022

  2024cites this paper
• What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?

  2024cites this paper
• A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma

  2024cites this paper
• Preoperative radiation therapy increases adherence in patients with high-risk extremity soft tissue sarcoma.

  2023cites this paper
• Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma

  2023cites this paper
• Survival Outcomes of Ewing Sarcoma and Rhabdomyosarcoma by High- versus Low-Volume Cancer Centres in British Columbia, Canada

  2023cites this paper
• Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas

  2023cites this paper
• Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data

  2023cites this paper
• Análise dos determinantes que influenciam no tempo até o diagnóstico de clientes com câncer

  2023cites this paper
• Zunehmende Schwellung am Oberschenkel

  2022cites this paper
• National evaluation of patterns and predictors of underuse of multimodal therapy for high-risk extremity soft tissue sarcoma.

  2022cites this paper
• Time-to-treatment initiation for cutaneous melanoma reflects disparities in healthcare access in Brazil: a retrospective study.

  2022cites this paper
• Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.

  2021cites this paper
• 30 /m – zunehmende Schwellung am Oberschenkel

  2021cites this paper
• Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database

  2021cites this paper
• Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?

  2020cites this paper
• CORR Insights®: Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?

  2020cites this paper
• Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma

  2019influential citation
• Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database

  2018cites this paper